2010
DOI: 10.1177/0269881110385594
|View full text |Cite
|
Sign up to set email alerts
|

Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults

Abstract: Extracts of sage (Salvia officinalis/lavandulaefolia) with terpenoid constituents have previously been shown to inhibit cholinesterase and improve cognitive function. The current study combined an in vitro investigation of the cholinesterase inhibitory properties and phytochemical constituents of a S. lavandulaefolia essential oil, with a double-blind, placebo-controlled, balanced crossover study assessing the effects of a single dose on cognitive performance and mood. In this latter investigation 36 healthy p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
89
0
1

Year Published

2012
2012
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 99 publications
(97 citation statements)
references
References 52 publications
7
89
0
1
Order By: Relevance
“…lavandulifolia , after a single oral dose of 50 μL, has shown to improve cognitive function in healthy humans compared to placebo, specially the performance of secondary memory and attention tasks (Kennedy et al, 2011). This effect has been mainly related to the inhibition of acetylcholinesterase by the oil, 1,8-cineol followed by α-pinene being the most active constituents (Perry et al, 2003; Kennedy et al, 2011). Taking in account the similarity in composition with the essential oil of S. blancoana subsp.…”
Section: Resultsmentioning
confidence: 99%
“…lavandulifolia , after a single oral dose of 50 μL, has shown to improve cognitive function in healthy humans compared to placebo, specially the performance of secondary memory and attention tasks (Kennedy et al, 2011). This effect has been mainly related to the inhibition of acetylcholinesterase by the oil, 1,8-cineol followed by α-pinene being the most active constituents (Perry et al, 2003; Kennedy et al, 2011). Taking in account the similarity in composition with the essential oil of S. blancoana subsp.…”
Section: Resultsmentioning
confidence: 99%
“…In a randomized study of 140 healthy young adults, inhalation of rosemary oil enhanced feeling of alertness and cognitive functions as evaluated using the Cognitive Drug Research (CDR) test battery used in the current study. 22 In a separate study the aroma of rosemary oil increased performance in exam students while increasing free radical scavenging activity and reducing cortisol levels. 42 However, to date there are no clinical studies on cognitive performance following ingestion of rosemary.…”
Section: Introductionmentioning
confidence: 97%
“…10 Additional studies have focused on cognitive changes brought about by herbal intervention in healthy older adults (e.g., for Bacopa monnieri, 11 Ginkgo biloba, [12][13][14] Centella asiatica, 15 and cranberry juice 16 ). Several investigations have been conducted into members of the mint family (Lamiaceae), 17 including lemon balm (Melissa officinalis), 18,19 sage (Salvia officinalis, Salvia lavandulaefolia), [20][21][22] lavender (Lavandula angustifolia), 23 and rosemary (Rosmarinus officinalis). 23 Rosemary (R. officinalis L., Family Lamiaceae) is native to the Mediterranean region, where the ancient Greeks revered it for stimulating the brain and assisting memory; 24 Dioscorides wrote of rosemary: ''the eating of its flower in a preserve comforts the brain, the heart and the stomach; sharpens understanding, restores lost memory, awakens the mind, and in sum is a healthy remedy for various cold ailments of the head and the stomach.''…”
Section: Introductionmentioning
confidence: 99%
“…Alzheimer's disease and other age-related memory disorders always remain key interest of researchers worldwide. AD is a slowly progressive disorder and is characterized by appearance of neurofibrillary tangles, neuritic plaques, rapid loss of synapses, and degeneration of basal cholinergic neurons [1] and disturbances in reasoning, planning, perception, and rational thinking [2, 3]. The number of individuals with AD in the USA is expected to be 14 million by the year of 2050 [4].…”
Section: Introductionmentioning
confidence: 99%